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Summary
Previous studies have located some twenty distinct sites
within the 2.3 kb 5' regulatory domain of the sea urchin
CyHIa cytoskeletal actin gene, where there occur in vitro
high-specificity interactions with nuclear DNA-binding
proteins of the embryo. This gene is activated in late
cleavage, exclusively hi cells of the aboral ectoderm cell
lineages. In this study, we investigate the functional
importance in vivo of these sites of DNA-protein interac-
tion. Sea urchin eggs were coinjected with a fusion gene
construct in which the bacterial chloramphenicol acetyl-
transferase (CAT) reporter gene is under the control of
the entire Cyllla regulatory domain, together with
molar excesses of one of ten nonoverlapping competitor
subfragments of this domain, each of which contains one
or a few specific site(s) of interaction. The exogenous
excess binding sites competitively titrate the available
regulatory factors away from the respective sites associ-
ated with the Cyllla • CAT reporter gene. This provides
a method for detecting in vivo sites within the regulatory
domain that are required for normal levels of ex-
pression, without disturbing the structure of the regulat-
ory domain. We thus identify five nonoverlapping re-
gions of the regulatory DNA that apparently function as
binding sites for positively acting transcriptional regu-
latory factors. Competition with a subfragment bearing
an octamer site results in embryonic lethality. We find
that three other sites display no quantitative competitive
interference with Cyllla • CAT expression, though as
shown in the accompanying paper, two of these sites are
required for control of spatial expression. We conclude
that the complex Cyllla regulatory domain must assess
the state of many distinct and individually necessary
interactions in order to properly regulate Cyllla tran-
scriptional activity in development.
Key words: sea urchin embryo, regulatory factors, in vivo,
Cyllla actin gene.
Introduction
The Cyllla cytoskeletal actin gene of the sea urchin
Strongylocentrotus purpuratus is transcriptionally acti-
vated late in cleavage in the presumptive aboral ecto-
derm territory of the embryo and, throughout embry-
onic development, the gene continues to be transcribed
exclusively in the aboral ectoderm (Shott et al. 1984;
Cox et al. 1986; Lee, 1986; Hickey et al. 1987). A
necessary and sufficient cis-regulatory domain extend-
ing approximately 2.3 kb upstream of the Cyllla tran-
scription start site, which promotes correct temporal
and spatial activation of a covalently associated CAT
reporter gene, has been identified by gene transfer
experiments (Flytzanis et al. 1987; Hough-Evans et al.
1987, 1988; reviewed by Davidson, 1989). The Cyllla
cw-regulatory domain includes about 20 sites where
there occur in vitro high-specificity DNA-protein inter-
actions. These have been located in gel shift mapping
experiments with specific oligonucleotide competitors,
using crude embryonic nuclear extracts (Calzone et al.
1988; Th6z6 et al. 1990). This set of sites includes 13
wholly non-homologous, distinct recognition se-
quences, some of which occur several times in the
Cyllla regulatory domain. There are unlikely to be
additional binding sites in any of the fragments used in
the competition experiments beyond those already
characterized, that is, for factors that display a mean-
ingful level of specific binding in vitro. Our objective in
the present work was to obtain evidence in vivo of the
functional significance of individual Cyllla protein-
binding sites, or of small subsets of locally contiguous
sites. The approach chosen was based on the prior in
vivo competition experiments of Livant et al. (1988).
There it was shown that coinjection with the
Cyllla • CAT fusion of low (2-20 x) molar excesses of
the whole regulatory domain per se (i.e. lacking the
CAT reporter gene) resulted in a near stoichiometric,
quantitative decrease in reporter gene activity as a
function of regulatory sequence: CAT reporter fusion
gene ratio (molar excess, as used here, refers to the
number of copies of competitor sites compared to
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Cyllla • CAT genes.) In the studies described in this and
the accompanying paper, we coinjected restriction frag-
ments containing subregions of the regulatory domain,
together with a near saturating number of complete
Cyllla • CAT genes. The significance of individual tar-
get sites (or small sets of target sites) on these subfrag-
ments was determined by assessing the activity of the
CAT reporter gene later in development. From this
approach two forms of information can be derived.
When the coinjected restriction fragments contain sites
of positive DNA-factor interaction that in vivo are
required for normal gene function, competition for
these specific factors depresses the level of CAT activity
measured in the transgenic embryos. In the ac-
companying paper, we show that ectopic spatial ex-
pression results from competition with other specific
regulatory target sequences, implying that the interac-
tions occurring in these sequences function in vivo to
control spatial expression.
Materials and methods
Preparation and injection ofS. purpuratus eggs
Unfertilized eggs were microinjected as previously described
(McMahon et al. 1985). Briefly, the eggs were dejellied by
exposure to pH5.0 filtered sea water (FSW) and fixed
electrostatically to protamine sulfate-coated dishes. Approxi-
mately 2 pi of a DNA solution was injected into the cytoplasm
of each egg. After injection the eggs were fertilized and
cultured at 15°C, in the same dishes, in FSW containing
penicillin (20 units ml"1) and streptomycin (50/xgml"1).
CAT fusion genes and whole regulatory domain
competitors
Two Cyllla • CAT fusion genes were used in these exper-
iments. The 14 kb Cyllla-CAT construct (Flytzanis et al.
1987) contains about 7 kb of genomic DNA extending 5' from
the transcription initiation site of the Strongylocentrotus
purpuratus Cyllla cytoskeletal actin gene, plus the 5' leader
sequence of the Cyllla primary transcript that is interrupted
by a 2.2 kb intron (Akhurst et al. 1987). The fusion point is a
Sad site located 11 codons following the start codon of the
Cyllla-CAT message. An SV40 poly(A) addition site and
plasmid sequences are also included. The Cyllla • CAT con-
struct was linearized for microinjection at a unique Sphl site
located about 2.5 kb upstream of the transcription start site
(see Fig. 1). A second fusion gene was created by in-frame
subcloning the 9.5 kb Sail fragment from Cyllla-CAT
(Fig. 1) into the CAT vector pUC.PL • CAT gene (Bond-
Matthews and Davidson, 1988). The vector was first modified
to create a Sail site (R. Franks et al. unpublished; Sucov et al.
1988). This fusion is called pCyllla-CAT-1. The 6.3 kb
Sphl-Kpnl fragment from Cyllla • CAT • 1 was gel purified
and used for microinjection (Fig. 1). This fragment includes
all necessary Cyllla regulatory sequences.
Subfragments of the Cyllla regulatory domain used as
competitors
Subfragments that were used for the in vivo competition
experiments were derived either directly from the Cyllla-
CAT construct, or from pUC 18/19 subclones of the Cyllla
regulatory region (Calzone et al. 1988; F. Calzone, R. Hill, E.
Davidson, unpublished), or equivalent Bluescript subclones
(A. Cutting and E. Davidson, unpublished) by digestion with
the appropriate restriction enzymes (see legend to Fig. 3).
The fragments were gel purified. Subfragments less than
approximately 1.0 kb in length were ligated in vitro to sperm
DNA (prepared as previously described; Lee et al. 1984). The
sperm DNA was digested with an appropriate restriction
enzyme to produce molecules of an average length of about
5.0kb, the termini of which would be homologous with the
competitor DNA termini, or blunt-ended if the competitor
DNA molecule bore a blunt end. Ligation reactions were
performed at 15 °C overnight in 20-50^1 that contained up to
10 jig of total DNA with an average molar ratio of competitor
DNA fragments/carrier DNA fragments of about 5.0. The
ligated DNA was digested with BgUl, an enzyme for which
none of the competitor DNA subfragments included a site,
and molecules ranging in size from approximately 1 kb to
15 kb were obtained for microinjection by fractionation in a
1% low-melt agarose gel, followed by purification by the
Geneclean (Bio 101 Inc.) procedure. Alternatively, the BglH-
digested DNA was size-fractionated by gel filtration through
Bio-Gel A-5m (BioRad). The actual concentration of the
specific competitor DNA sequence in the final sample used for
injection was measured by slot-blot hybridization, using a
single-stranded RNA probe. Known numbers of linearized
Cyllla- CAT DNA molecules were included on each filter as
standards. Typically, the competitor DNA sequence was
present at an average density of about 3.4 copies per 5 kb of
carrier DNA in the sample (all samples used fell within the
range 2-6 copies per 5 kb carrier DNA except the P7I
ligation, which was injected at 1 copy per 5 kb). A few
deviations are noted in the legend to Fig. 3.
Microinjection solutions
Each DNA solution was made up in 40% glycerol and
contained 550-2000 molecules of a CAT fusion gene per pi,
together with competitor DNA and/or carrier DNA (see
text). The DNA mass in each injection solution was adjusted
by the addition of carrier to yield at least a 5-fold mass excess
of carrier DNA plus competitor DNA, over CAT DNA, and
to ensure that each injection sample in a given experiment
contained the same total DNA concentration.
Measurement of CAT enzyme content per embryo
Embryos were analyzed for CAT enzyme content at 20-24 h
postfertilization (hatched blastula) as previously described
(McMahon et al. 1984), using lysates derived from 40-60
injected embryos and a series of bacterial CAT enzyme
standards. Under our conditions, one unit of CAT enzyme
activity equals ~2.6xlOu molecules of enzyme, as estab-
lished earlier by reference to a purified recombinant CAT
enzyme preparation (McMahon et al. 1984).
Measurement of CAT DNA and competitor DNA
content per embryo
DNA measurements were made at 24 h postfertilization by a
modification of the slot-blot procedure described earlier
(Flytzanis et al. 1987; Franks et al. 1988). Centrifugal pellets
containing 60-130 injected embryos or uninjected control
embryos were mixed in 50 )A of 250 mM Tris-HCl, pH 7.8 with
— 100 gastrula stage Lytechinus variegatus embryos used as
carrier. An equal volume of 0.1 M EDTA, pH 8.0, 0.2 M NaCl,
1% SDS was added, and the samples were incubated with
20 ng of proteinase K for 3h at 55 °C. The nucleic acids were
extracted and treated with 0.4 M NaOH at 65°C to denature
the DNA and hydrolyze the RNA, and were filtered onto
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nitrocellulose using a slot-blot apparatus as previously de-
scribed. For hybridization standards known numbers of
Cyllla-CAT DNA molecules, linearized with Sphl, were
mixed with L. variegatus carrier nucleic acids, treated with
0.4M NaOH as described above, and applied to each filter.
These standards of course include all of the different competi-
tive sequences, since the whole regulatory domain is present
in Cyllla • CAT (see Fig. 1) as well as the CAT gene sequence.
The slots were cut exactly in half, and the halves were
separately hybridized with single-stranded RNA probes con-
taining sequences representing either the CAT gene (Flytzanis
et al. 1987) or the Cyllla 5'-sequence used for in vivo
competition. Probe specific activities were about
l.SxlO'ctsmin'Vg"1- Hybridizations with the CAT probe
were carried out at 40 °C in 50% formamide as described
(Franks et al. 1988). Hybridizations with the Cyllla 5'-
competitor sequence probes were performed at temperatures
calculated to maximize hybridization efficiency based on G-C
content (Casey and Davidson, 1977). The filters were washed
twice with 2xSSC (lxSSC is 0.15M NaCl, 0.015M sodium
citrate), 0.2% SDS at room temperature, twice with 2xSSC,
0.2% SDS at 68°C, and twice with 0.75xSSC, 0.2% SDS at
68 °C. Following autoradiography, each half-slot was cut out
and counted; quantitation of CAT DNA sequences or Cyllla
5'-competitor DNA sequences in each half-slot was made by
comparison to the signal obtained for hybridization between
each probe and the Cyllla • CAT DNA standards on each
filter. The competitor DNA sequence probes also hybridized
with the incorporated Cyllla • CAT sequences present in each
half-slot of DNA extracted from the injected embryos.
Therefore, the number of competitor DNA molecules in
excess of CylTIa • CAT genes in a given half-slot could be
determined by subtracting the number of Cyllla • CAT DNA
molecules that was calculated to be present (using the
corresponding half-slot hybridization signal obtained with the
CAT probe) from the total number of sequences that hybrid-
ized with the competitor DNA probe. Thus the molar ratio of
incorporated competitor DNA:CyIIIa-CAT DNA in the
transgenic embryos was obtained. The number of CAT DNA
molecules and competitor DNA molecules present per half-
slot was also computed in terms of average numbers of
molecules per embryo.
Competitive efficiency coefficient a
The competitive in vivo titrations carried out with the whole
regulatory domain by Livant et al. (1988) indicated that the
efficiency of competition in vivo was about 44% of ideal
expectation. This was established by deriving a competition
efficiency coefficient, a, given the form y=(l + ax)~1, where y
is the CAT activity relative to the control, in which
Cyllla • CAT but no competitor DNA is introduced into the
embryos; and x is the molar ratio of competitor to
Cyllla • CAT DNA actually incorporated in the experimental
embryos. Were o=l , the factor binding sites included in the
incorporated Cyllla • CAT genes, and those in the incorpor-
ated competitor regulatory domains, would have competed
with equal efficiency for the limiting DNA binding factors.
The microinjection gene transfer system utilized in both the
experiments of Livant et al. (1988) and those described in this
paper, produces a mosaic, though random, pattern of exogen-
ous DNA incorporation (McMahon et al. 1985; Flytzanis et al.
1985; Hough-Evans et al. 1987; Franks et al. 1988; see Livant
et al. 1988). Thus, a probable explanation for the ~2-fold
discrepancy from ideal behavior in the experiments of Livant
et al. (1988) is that the cells incorporating and expressing
Cyllla • CAT in their genomes are not invariably the same
cells that incorporate all the competitor sequences.
Results
Competitive titration using the entire Cyllla regulatory
domain
Previously published gene transfer studies demonstrat-
ing that correct spatial and temporal expression is
mediated by upstream Cyllla sequence were carried
out with the Linearized Cyllla • CAT fusion (Flytzanis et
al. 1987; Hough-Evans et al. 1987, 1988), and this
construct was also used in some of the experiments we
report here. A second construct, pCyllla-CAT-1,
utilized in other experiments, is shown diagrammati-
cally in Fig. 1A. Expression of the 6.3 kb Sphl-Kpnl
fragment of pCyllla • CAT • 1 in transgenic embryos is
indistinguishable from that of Cyllla • CAT in quanti-
tative, temporal, and spatial respects. On microinjec-
tion into sea urchin egg cytoplasm, linear DNA mol-
ecules of these lengths are rapidly ligated, irrespective
of the DNA termini, into long end-to-end concatenates
that are stably incorporated into one or more blasto-
mere nuclei during cleavage, and are replicated
together with host cell DNA throughout embryogenesis
(McMahon et al. 1985; Flytzanis et al. 1985). No
differences were detected in the degree of amplification
of any of the fusion genes or competition fragments
within experiments.
In an initial series of experiments, fragments contain-
ing the complete set of detectable protein-binding
sequence elements were used as in vivo competitors in
order to provide base line stoichiometry for comparison
with the competitive effects of individual subfragments.
In Fig. 2 we present new data that substantiate the
observation (Livant et al. 1988) that quantitative com-
petitive titrations can be obtained in vivo in sea urchin
embryos. This Fig. shows the pooled 'whole regulatory
domain' controls for the subfragment competition ex-
periments presented in the following. For each point in
Fig. 2, at least 1200 molecules of the Cyllla • CAT
reporter, plus the indicated numbers of competitive
DNA molecules (9.5 kb Sail or 4.3 kb Ncol-EcoRl
fragments, see Fig. 1) were injected. At least a 5-fold
mass excess of carrier and/or competitor DNA was
coinjected with the Cyllla-CAT genes. The carrier
used was sea urchin sperm DNA, cut to a mean length
of 5 kb. Thus the individual Cyllla • CAT genes in the
incorporated concatenates were distributed around a
mean distance apart of 30-70 kb (depending on whether
the 14 kb Cyllla-CAT or the 6.3 kb Sphl-Kpnl frag-
ment was used), interspersed among randomly selected
sequences; or, in the competition samples, among
various ratios of Cyllla regulatory domain and 5 kb
randomly selected sequence. Preliminary experiments
had shown that the Cyllla • CAT gene functions 2-3 x
more efficiently when separated by 2^3.5-fold excess of
carrier (possibly due to transcriptional interference in
the absence of carrier). Within each experimental series
of Fig. 2, the various competition samples and the
reference sample, in which Cyllla • CAT and carrier but
no competitor had been introduced, all received exactly
the same total mass of DNA per egg; i.e. the carrier
DNA content was adjusted to take into account the
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Fig. 1. Structure of the pCyllla • CAT • 1 gene fusion, locations of sites of in vitro interaction between nuclear factors and
Cyllla 5'-flanking sequence, and competitor DNA fragments. (A) Map of pCyllla • CAT • 1. Hatched areas represent sea
urchin sequences, including the 2.2 kb first intron contained within the Cyllla primary transcript (Akhurst et al. 1987). The
fusion point is a Sail site located 11 codons following the start codon of pCyllla • CAT • 1. An SV40 poly(A) addition site is
included, together with plasmid sequences. The 6.3 kb Sphl-Kpnl fragment derived from the pCyllla-CAT-1 fusion gene
was used for microinjection. Alternatively, the Cyllla • CAT fusion gene (not shown) described by Flytzanis et al. (1987) was
linearized at the Sphl site located 2.5 kb upstream of the Cyllla transcription start site, and used for microinjection. (B) Map
of the Cyllla cw-regulatory domain, and competitor DNA fragments. The locations of all known sites of in vitro interaction
between sequence elements in the 5'-flanking regulatory region of the Cyllla gene and nuclear factors are depicted by black
boxes within the 2.5 kb Pstl-BamHI fragment. The protein-DNA interactions described by Th6z6 et al. (1990) for each
binding site are indicated (P1-P8). The PI binding region actually extends into the 5' end of the first exon of the Cyllla
gene. The 9.5 kb Cyllla Sail fragment and the 4.3 kb Ncol-EcoRl fragment (indicated above the map), each of which
contains the entire regulatory domain, were used as competitor in the in vivo competition experiments shown in Fig. 2.
DNA subfragments of the regulatory region (shown below the map) that contain the indicated factor-binding site(s) (or no
binding site, x) were released from pUC subclones (Calzone et al. 1988) by digestion from the polylinker with EcoRl and
HindlU (P1-P3, P4-P6, x) or HindUl (P5), or from pBluescript subclones (A. Cutting, E. Davidson, unpublished data) by
digestion with BamHl and HindlU (P3A, P7I). Fragment P3B was derived from fragment P3 by digestion with HinQ. These
fragments were ligated to sea urchin carrier DNA molecules bearing termini homologous with the specific fragment and
prepared for microinjection as described in Materials and methods, and were subsequently used for the in vivo competition
experiments shown in Fig. 3 and Table 1. Restriction sites shown are: a, Avail; b, BamHl; d, Ddel; dr, Dral; h, HindUl;
ha, Haelll; hi, Hintt; hp, HpaU; k, Kpnl; n, Ncol; p, Pstl; r, Rsal; e, EcoRI; s, Safl; sp, Sphl.
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Fig. 2. Competition in vivo between the CylUa 5'-
regulatory domain and coinjected Cyllla • CAT reporter
genes. At least 1200 molecules of a Cyllla • CAT gene
fusion were injected at each point, together with varying
numbers of either the 9.5 kb Sail DNA fragment or the
4.3 kb Ncol-EcoBJ DNA fragment, containing all known
sites of in vitro interaction between the Cyllla 5'-regulatory
region and nuclear factors (see Fig. IB) as competitor. The
molar ratio of competitor sequence to Cyllla • CAT
sequence incorporated at each point was measured by
slot-blot hybridization of DNA extracted from samples of
pooled transgenic embryos, using 32P-labeled probes
specific for each sequence, as described in Materials and
methods. A second aliquot of embryos was pooled and
assayed for CAT activity at each point. The relationship
between CAT activity per embryo relative to the CAT
activity per embryo (normalized to 1.0) in the control in
which no competitor DNA was included (y), and molar
ratio, (x), of competitor DNA molecules to Cyllla • CAT
genes, can be approximated as y=(l+ox)~\ where a-is the
competition efficiency coefficient, and provides an estimate
of the fraction of competitor fragments actively functioning
as competitor (Livant et al. 1988; see legend to Table 1).
The dashed curve indicates the ideal form, i.e. where
<x=\.0. The solid curve is the least squares fit to the
experimental data, and yields a value for or of 0.76 [Livant
et al. (1988) obtained a-=0.44 in similar experiments;
considering the scatter there may be no real difference
between these results, nor any real discrepancy from an a
value of unity]. Twenty-six experiments are shown. Each
unique symbol represents an experiment carried out with a
single batch of eggs. Cyllla • CAT gene fusion and
competitor DNA fragment used are: solid symbols (black or
white), 6.3kb Sphl-Kpnl pCyllla • CAT • 1 fragment plus
9.5 kb Sail competitor DNA fragment; cross-hatched
symbols, Sphl-liaear CylUa • CAT (Flytzanis et al. 1987)
plus 9.5 kb Sail competitor DNA fragment; right-shaded
symbols, Sp/il-linear Cyllla • CAT plus 4.3 kb Ncol-EcoW
competitor DNA fragment.
mass of competitor DNA added to obtain the nominal
competitor/fusion gene molar ratio desired. The total
DNA mass injected was about 0.2 pg/egg.
As in our previous studies (op cit) average CAT
enzyme content per embryo in the reference samples
that contained no competitor was generally
1.0-3.0X107 enzyme molecules per embryo. To pool
the data shown in Fig. 2 these values have been used for
normalization of the CAT enzyme content in the
embryos within each experimental series. The CAT
enzyme was measured in samples of 24 h embryos, and
in Fig. 2 is expressed as a function of the molar ratio of
competitor to Cyllla • CAT genes actually incorporated
per average embryo. These ratios were directly
measured in aliquots of the same embryo samples by
slot-blot hybridization, using competitor DNA and
CAT DNA sequence probes. The experimental data fit
by the solid line in Fig. 2 indicate that CAT activity falls
off at a rate that is almost stoichiometric, with respect to
the number of competing 5' regulatory sequences
present. The best fit value from the pooled data of
Fig. 2 yields a=0.76 (see legend of Fig. 2). Thus we
have used <*=0.76 as a normalization factor in most of
the following experiments. These data clearly confirm
that endogenous factors required for the expression of
the Cyllla • CAT fusion gene can be titrated away from
the fusion gene by introduction of excess DNA binding
sites.
Competitive titration in vivo by subelements of the
Cyllla regulatory domain
To determine the effects on Cyllla • CAT gene activity
of titrating away those factors binding to individual
subregions of the large regulatory domain, we coin-
jected various molar excesses of the subfragments
identified in Fig. IB. Many of these subfragments were
also utilized for the gel-shift experiments of Calzone et
al. (1988) by which the sites of interaction were initially
located, and we have adopted the same subfragment
nomenclature in the present account. Several include
only a single site of DNA-protein interaction. How-
ever, the PI, P2 and P6 subfragments contain two sites
of interaction, and the P8 subfragment, which is par-
ticularly complex, includes at least 8 protein-binding
elements of three different classes (Th6z6 et al. 1990).
Two subfragments that do not contain sequences that
form DNA-protein complexes in vitro on reaction with
embryo nuclear extracts are also shown on the map (X
in Fig. IB). Neither of these subfragments displayed
any competitive function in our hands (results not
shown), nor do subfragments extending 5.3 kb
upstream of the SphI site (see Fig. 1A). In initial studies
we found that microinjection of small DNA fragments
(<lkb) does not reliably result in measurable repli-
cation during embryogenesis, probably due to failure to
form concatenates that are sufficiently large to promote
stable incorporation. To circumvent this problem each
of the competitor DNA subfragments shown in Fig. IB,
with the exception of the large subfragment containing
the whole P8 binding region, was first ligated in vitro to
carrier genomic DNA. The actual concentration of the
specific competitor sequence in each ligated DNA
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preparation was measured by slot-blot hybridization,
using a 32P-labeled RNA probe.
In each injection series, eggs obtained from a single
female were coinjected with at least 1200 molecules of a
Cyllla • CAT gene, together with increasing quantities
of competing sequence that were always in molar excess
with respect to the Cyllla • CAT DNA. Competition
curves obtained in vivo for each of nine nonoverlapping
subfragments that were derived from the Cyllla
regulatory domain are shown in Fig. 3. The average
CAT enzyme content and the average competitor
DNA:Cyllla • CAT DNA ratio were measured in
pooled embryo samples at 24 h. The average exogenous
DNA amplification in the various injection samples
within a given experiment was similar, and in different
batches the values measured in the 24 h embryos ranged
from about a 10-fold to an 80-fold increase over the
amount of DNA injected per egg. Normalized exper-
imental data were fitted to the same form describing the
competition stoichiometry as above, and for each ex-
periment a value for the competition efficiency coef-
ficient a was derived by nonlinear least squares. In
Fig. 3, competition functions are shown for each of 10
subfragments that contain known sites of DNA-protein
interaction identified in vitro. These are presented in
order of descending or values; i.e. the best competitors
first, and the least effective last. The curve representing
perfect competition stoichiometry (a=l) is shown as a
dotted line in each panel for comparison.,Fig. 3A-F
demonstrates immediately that a majority of the non-
overlapping subfragments tested function individually
as competitors against the whole Cyllla regulatory
domain, and the P4, P5 and P8 subfragments each
appears to compete as well as does the whole regulatory
domain. Each of these regions apparently contains an
essential positive regulatory site(s) bound by a factor or
factors of limited availability relative to the number of
competitor fragments incorporated. Fig. 3G-J shows
that subfragments containing the binding regions for
P6, P3, P3A and P7II, respectively, displayed relatively
insignificant competitive activity.
Quantitative data for these and some additional
experiments are listed in Table 1. The values given by
the parameter of in the second column of Table 1
estimate the competitive effect of the indicated subfrag-
ment in each experiment, relative to the competition
obtained with the complete regulatory region. Pooled
data for multiple experiments with given subfragments
were used to assess the best overall value of the
competition coefficient, given as af in the third column
of Table 1. Each of five different regions, i.e. those
containing binding sites for P2, P4, P5, P7I and P8,
compete between 10 % and 100 % (or better) than does
the whole regulatory domain (i.e. a^  3=0.1). An a! value
of 1.0 would indicate that the competitive effect of the
subfragment is equal to that of the fragment containing
the entire regulatory domain. The a! values for DNA
subfragments containing the binding sites for P3, P3A,
P6 or P7II are below 0.1, and that for PI is just above
0.1. As discussed below, this result is unlikely to be due
simply to high prevalence of the respective factors.
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Fig. 3. In vivo competition by subelements of the Cyllla 5'-
regulatory region in transgenic embryos. At least 1200
molecules of a Cyllla • CAT gene fusion were injected at
each point, together with varying numbers of competitor
fragments that contain the binding regions for the indicated
set of DNA-binding factors (Th6ze et al. 1990; see Fig. IB).
The relationship between average CAT activity per embryo
and the average molar ratio of competitor DNA molecules
to Cyllla • CAT molecules incorporated is expressed as in
Fig. 2. The competition coefficient a (i.e. where ideal
stoichiometric competition would generate a value for a of
1.0) calculated for the whole regulatory domain in Fig. 2
was used as a normalization factor to correct the individual
data points in these experiments (see legend to Table 1), so
that the competitive effect of the individual fragments
would be compared directly to the effect of the whole
domain. Thus, the dashed curves in A-J indicate the
competitive behavior of the entire regulatory region. The
solid curves, fit by least squares, indicate the behavior of
the individual subfragments. Competition is near
stoichiometric in A-C. There is little, if any, competition in
F-J. Panels A-C, E, G, H, J show the least squares fit to
the pooled experimental data obtained from more than one
experiment. The data for the eighteen experiments shown
here were derived from a subset of those experiments used
to generate the value of a for the whole regulatory domain
shown in Fig. 2 (data points from a single experiment are
described by matching symbols in these figures).
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Table 1. Competitive effect in vivo of subfragments of
the Cyllla 5'-regulatory domain
Competitor
Cyllla subfragment*
P2
P4
P5
P7I
P8
PI
P3
P3A
P6
P7H
Experiment
1
2
1
2
1
2
1
1
2
1
1
2
3
4
1
1
2
3
1
2
0.17(0.11)
0.25* (0.24)
2.5 (0.01)
1.1 (0.1)
0.29 (0.04)
0.92(0.10)
0.24 (0.7)
0.24 (0.14)
2.2 (0.18)
0.13 (0.03)
0.02§ (0.04)
0.14§ (0.09)
0.O4 (0.17)
0.06(0.17)
0.04(0.16)
0.09* (0.21)
0.07* (0.00)
0.12 (0.05)
0.01 (0.23)
0.003 (0.06)
0.21 (0.19)
1.8 (0.02)
0.47(0.12)
1.7 (0.22)
0.04 (0.18)
0.09 (0.15)
0.04(0.17)
* Each competitor subfragment is derived from the entire CylTIa 5'-
regulatory domain, and contains the binding regions for the sets of DNA-
binding factors indicated in Fig. IB (Theze' et al 1990; Calzone et al. 1988).
t The relative activities of the Cyllla • CAT reporter gene in the presence
of molar excesses of the indicated competitor DNA subfragment in each
experiment were normalized, usually by the value for the competition
efficiency coefficient estimated from the pooled control data shown in Fig. 2.
This value was a=0 76. To carry out the normalizations the following
procedure was used, y, is the CAT activity measurement (average molecules
CAT enzyme/embryo in the competition sample, relative to the average
molecules CAT enzyme/embryo in the control sample in which no
competitor DNA was included; see Materials and methods), x, is the molar
ratio [subfragment:CyIIIa'CAT] actually incorporated, by direct
measurement (see Materials and methods); N is the competition efficiency
coefficient indicating the fraction of competitor functioning in a manner
quantitatively equivalent to the respective site(s) on the incorporated
Cyllla-CAT molecules. In general for this competition, y=(l+ox)~' (Livant
et al. 1988). The normalized values denoted y(c;xj) are calculated as follows:
y(c;xi) = J
where N is the value of crused for the normalization, and y(l;x))+(l+X|)~1;
y(N;x))=(l+Nxi)"1. As noted above N was usually 0.76, except for a few
cases, indicated (see below) in which there were sufficient internal control
data, so that N was derived from that experiment rather than from the
pooled data. The resulting data reduction in these cases was m fact never
significantly dependent on whether the internal control or the pooled value
0.76 were used for the normalization. Internal controls were routinely used
as a qualitative screen for occasional batches of eggs in which for some
reason even the control competition functioned not at all or very poorly,
probably because these eggs did not adequately support exogenous DNA
amplification. The normalized yc(Xj), X| values were fit to yc(xi)=(l—o'xi)"1
by least squares, and the values of a1 are those reported in the Table for the
individual subfragment experiments. For the last column of Table 1 all of the
y<Xxi) values were pooled, the data were refit, and an of value established by
least squares Root mean square errors are reported in parentheses.
$For these experiments, we used individually determined efficiency
coefficients to obtain o/, rather than 0 76 (i.e., individually determined
values of N, as in note t; here the value for a-for the Cyllla'CAT control
with the whole regulatory domain competitor in each of these particular
experiments). For P2, experiment 2, N=0.96; for P6, experiment 1, N=0.73;
P6, experiment 2, N=0.31.
§ Measurements of CAT DNA and competitor DNA content per embryo
were not made in these experiments. The values calculated for a' were
estimated based on the subfragment/CAT DNA molar ratios introduced into
each egg. These experiments were not utilized in calculating a'.
Lethal effects of competitive titration of the P3B
binding site
The site labeled P3B in Fig. 1 includes a canonical
octamer binding site (The^e" et al. 1990). Uniquely
among all the subfragments tested, competition with a
subfragment containing only this site results in the
death of 60 % to over 95 % of the recipient embryos, by
the pluteus stage, in different experiments. In controls
for these particular experiments, 95-100% of eggs
injected only with a saturating number of Cyllla • CAT
molecules plus carrier DNA developed through hatch-
ing blastula stage, and 70-80% completed embryogen-
esis normally. The same P3B injection solution that is
lethal to recipient embryos is rendered harmless if
treated with DNase prior to injection.
The unusual lethality of P3B competition is particu-
larly interesting because as shown earlier the adjacent
P3A site, when injected on a fragment by itself, does
not display competitive activity (Fig. 31; Table 1), and
when the Hindlll-Ddel 'P3' subfragment, which in-
cludes both the P3A and P3B sites (see Fig. 1A) is
injected, the results are the same as when the P3A
subfragment alone is injected (see Table 1). That is,
there is no significant competitive activity {a1 is about
0.04 for both subfragments), and no lethality is ob-
served. The P3B factor is evidently required for the
expression of genes that are necessary for viability, a
not unlikely possibility since octamer binding sites have
been reported in a great many different genes in
mammals, and in several sea urchin histone genes as
well (Barberis etal. 1987). That the presence of the P3A
site on the same competitor fragment with the P3B site
'rescues' the embryos from the lethal effects of P3B
competition suggests that, when P3A is bound at the
adjacent sites, the essential P3B octamer factor is
precluded from binding, and thus is not sequestered
away on the competitor fragments.
Discussion
Competitive titration of positively acting factors within
the embryo nuclei
Livant et al. (1988) showed that as the number of
Cyllla • CAT genes per embryo nucleus is increased,
over a range from a few to several thousand, the
amount of CAT enzyme expressed attains a plateau,
after an initial phase in which CAT activity rises
proportionally with incorporated gene number. The
kinetics of the response can be fitted to the expected
form for a saturation phenomenon. This is an interest-
ing result which it is necessary to consider briefly before
taking up the nature of the competitions that we present
in this paper. About 90 % saturation of Cyllla • CAT
expression occurs at 1050 specific sites per nucleus,
implying that the limiting factors required for Cyllla •
CAT expression are 90 % bound to specific sites at this
level (D. Livant and E. Davidson, unpublished). In the
present experiments, we tried to approach saturation
conditions by injecting ^1100 molecules of Cyllla-
CAT per egg, plus in the competition samples, molar
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excess of the individual sites being tested. On the
saturation plateau, the excess sites compete with one
another for factor molecules. As the site concentration
increases in the nuclei, these factors progressively
repartition from the non-specific sites with which they
are reversibly associated to the added specific sites,
according to the particular values of the partition
function Kr that obtain for each factor in vivo (Kr is the
ratio of equilibrium constants for reaction of a given
factor with its specific sites to that for reaction with non-
specific DNA sites). Cooperative binding amongst the
many different factors required for productive ex-
pression of Cyllla • CAT, or additional stabilization of
active transcription complexes, is also implied. Other-
wise, as excess copies of the regulatory domain are
introduced, the factors would distribute independently
amongst them. The number of completely loaded
regulatory domains would thus decrease, and a decline
in activity rather than the saturation plateau observed
convincingly by Livant et al. (1988) would result.
The experiments shown in Fig. 2 confirm the evi-
dence of Livant et al. (1988) that when the whole
regulatory domain is introduced in molar excess with
respect to saturating levels of Cyllla • CAT, compe-
tition for necessary factors occurs in vivo. This is
reflected by an almost stoichiometric decrease in CAT
expression, as a function of competitor:CyIIIa • CAT
molar ratio. When similar competition is observed
following introduction of molar excesses of a given site,
as in the experiments of Fig. 3, these competitor sites
therefore must effectively titrate away the factor species
that recognizes them specifically. However, we have not
shown explicitly that the competitive effects are direct.
For example the striking P5 competition shown in
Fig. 3C could be an indirect result, were the seques-
tration of the P5 factor actually to affect some regulat-
ory gene, that in turn produces some other factor that
affects Cyllla • CAT expression. The improbability of
such an interpretation depends on the frequency with
which factors required for regulation of the Cyllla gene
are also required for regulation of genes whose prod-
ucts are necessary for Cyllla expression, e.g. these
same factors, or polymerase components, aspects of
processing mechanism, etc. Needless to say, that fre-
quency cannot yet be assessed. But, it is worth noting
that in two cases where there is relevant deletion
evidence, the same result is obtained by both deletion
and competition methods. Flytzanis et al. (1987)
showed that severe depression of Cyllla • CAT ex-
pression results from excision of the P8 sites (their ASP,
ASPP deletions), or of the P5 site (their AH deletion, in
which exactly the same fragment was removed from
Cyllla • CAT as was used for the experiments of
Fig. 3C). It follows that the strong competitions shown
for the P5 and P8 sites in Fig. 3B and 3C are indeed
direct rather than indirect effects. More generally,
however, it is useful to recognize that excess site
competition, and site deletion followed by gene trans-
fer, are complementary rather than redundant ways of
probing the significance of regulatory interactions in
vivo. Deletion does indeed reveal site function directly,
but in the context of more or less disturbed cis-
regulatory DNA structure. While this may usually be of
secondary or no importance, interaction between
bound factors could depend in given cases on regulatory
domain structure. In one example, a cardiac myosin
light chain gene in which the relevant sites are closely
apposed, intranuclear competitive titration yielded con-
sistent results where deletion did not (Braun et al.
1989). Recently competitive titration has been used in
studies of the regulatory molecular biology of sea
urchin embryo histone genes (Lai et al. 1989), human
actin genes (Muscat et al. 1988) and a gut-specific
esterase gene of C. elegans (McGhee, personal com-
munication).
Identification of positively acting Cyllla regulatory
sites
The surprising result from the experiments shown in
Fig. 3 and Table 1 is that out of ten subfragments tested
five include sites that compete effectively at low molar
excess with respect to Cyllla • CAT expression. These
are, in order of their competitive potency, the subfrag-
ments containing the P4, P8(I+II+III), P5, P7I and
P2(I+II) sites. In addition, the PI factor may compete
weakly and P3B octamer factor is clearly necessary,
though its role in Cyllla gene regulation remains
unspecified, since its sequestration in a minor fraction
of cells is lethal to the embryos. The positively acting
factors listed here are probably entirely different and
independent of one another, since the sequences to
which they bind are wholly distinct (Th6z6 et al. 1990),
and in vitro measurements indicate that these factors
are of different prevalences (Calzone et al. 1988).
Furthermore, these particular factors accumulate in the
embryo with different kinetics (Calzone et al. 1988),
and interact with different unique sets of genes (Thie-
baud et al. 1990). The three most potent competitors are
those subfragments bearing sites for factors P4,
P8(I+II+III), and P5. In all of these cases, the indi-
vidual subfragment competes within a factor of two as
efficiently as does the whole regulatory domain. Con-
sidering the statistical nature of these observations, and
the failure of the whole domain to compete ideally
(cr=0.76; Fig. 2), it seems reasonable to conclude that
the competitive efficiencies of these subfragments can-
not be distinguished from that of the whole regulatory
domain. Thus, each of these subfragments must be the
site of absolutely required, positive interactions, with-
out which Cyllla • CAT activity is minimal. The preva-
lence of the P4, P8 and P5 factors in the embryo nuclei
is close to that of the Cyllla • CAT gene introduced in
our competition experiments (i.e. ~500 molecules/
nucleus of P4 and P5, and about 1500 of the P8 factors).
This prevalence will be rapidly exceeded as molar
excesses of competitor sites are introduced. P4 is a
CCAAT factor and the essentiality of this interaction is
thus not surprising, though it may be noted that there
are probably several different CCAAT binding factors
in sea urchin embryos (Barberis et al. 1987). Although
molar excesses of sites should also have been attained in
vivo for the relatively rare P7I factor (~200 copies/
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nucleus) and for PI (~1100 copies/nucleus), compe-
tition in these cases is. only around one-fourth to one-
sixth as efficient as with the whole domain. Unless the
PI and P7I factors are distributed to only a small subset
of cells, in which their concentrations per nucleus would
be 5-10x higher, it can be concluded that these
interactions are not individually absolutely required for
Cyllla-CAT function, as are those mediated by the
sites on the P4, P8 and P5 subfragments. Yet they are
necessary for maximum activity.
There can be two reasons for failure of competition
when competition sites are introduced: factors with
relatively low Kr will not partition to the added sites
efficiently; and for factors that are very prevalent it is
more difficult to introduce a true excess of specific sites.
High endogenous factor prevalence (—6000 copies/
nucleus) could easily explain the relatively weak com-
petition'displayed by the P2 subfragment. The number
of Cyllla • CAT genes plus competitor would only begin
to exceed the number of P2I and P2II factor molecules
at the highest molar excesses utilized (cf. Fig. 3E). Thus
it cannot be excluded that one or both of the P2 factors
is not as essential as at least one of the P8 and the P4
and P5 factors; that is, that the efficiency of P2
subfragment competition is depressed to about one-
fifth of the competition efficiency of the whole domain
only because of failure to achieve site/factor ratios
equivalent to those in the other experiments shown. It is
not feasible to introduce greater masses of DNA
without incurring risk of embryo lethality irrespective
of the sequence injected (McMahon et al. 1985). On the
other hand, the almost complete failure of the P3A, P6
and P7II subfragments to compete effectively cannot be
explained simply in the same way. The average num-
bers of molecules of these factors per nucleus are not
very different than those for which clear competition
was obtained (P3A, —720 molecules/nucleus; P6,
-2800 molecules/nucleus; P7II, -1480 molecules/
nucleus; Calzone et al. 1988). Though the Kr values of
these factors differ (Calzone et al. 1988), they are all
sufficiently high so that competition should have been
observed at the molar ratios actually achieved, were
these positively acting factors required for embryonic
Cyllla • CAT expression.
The Cyllla regulatory domain is a logic switch
Interference with the interactions so far discussed
depresses Cyllla • CAT function in vivo, but in all cases
the residual expression is spatially correct. As shown in
the accompanying paper (Hough-Evans et al. 1990), in
embryos with reduced Cyllla • CAT function due to in
vivo titration, CAT mRNA is still confined to aboral
ectoderm cells. While these interactions are all positive
in sense, the P3A and P7II subfragments, which do not
competitively titrate down Cyllla • CAT activity (Fig. 3
and Table 1), function in vivo as negative regulators of
spatial expression. Viewed as a functional unit, the
Cyllla regulatory domain can be seen to require that a
number of distinct factor-site interactions take place in
order for the gene to function properly in time, in space
(i.e. cell lineage) and in amplitude. The inference from
what we are learning about this developmental gene
regulatory system is that the multiple interactions it
requires are not, as may appear superficially, redundant
in a functional sense. They exist to carry out diverse
biological functions. Perhaps each bears a specific
functional relation to the biological status of the cell,
that is, to developmental stage, state of specification or
lineage, etc. In the case of the P8 and P5 factors, for
example, which seem at first sight to function redun-
dantly, i.e. as essentially positive regulators (this
paper), we have good reason to suspect quite different
biological roles. The P8 factors are present in the
embryo before the Cyllla or Cyllla • CAT genes are
activated, and their concentration remains unchanged
as development proceeds (Calzone et al. 1988). Thus
they are unlikely to be responsible for temporal acti-
vation, but to be needed as amplitude controllers. On
the other hand, the same study shows that the P5 factor
rises dramatically over the same period in which this
and other aboral ectoderm genes are turned on (David-
son, 1989). P5 could control this important temporal
developmental function, since it too is essential for
expression, and this factor is probably utilized in the
regulatory domains of several other genes that are
activated at the same stage of development (Thiebaud
et al. 1990). Thus we think of the Cyllla regulatory
system as a developmental logic switch, in the sense that
it converts the multielement pattern of individual,
functionally diverse interactions within it, into a single
scalar function, viz. increase (or decrease) in the rate of
transcriptional expression.
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